Lumanity’s Post

Discussions in the industry are progressing from ‘why’ to ‘how’ to ‘now’ when involving patients in clinical research design. Our experts have identified some key themes that emerged from both the US and European Patients as Partners in Clinical Research conferences, that took place in March and May respectively. Some of these trends and themes include: - More consistent and earlier approach to patient focused drug development (PFDD) - Equitable access to research including health literacy and diversity, equity and inclusion - Measuring impact of patient engagement in research - Improving the sponsor, site and study participant partnership - Participant data release in clinical trials - Compensation for study participants Read the full report to access our key themes and reflections at https://buff.ly/3XPY7uj #PatientsasPartners #ClinicalResearch #PFDD #patientengagement #medcomms #healthliteracy #patients

Discussions in the industry are progressing from ‘why’ to ‘how’ to ‘now’ when involving patients in clinical research design. Our experts have identified some key themes that emerged from both the US and European Patients as Partners in Clinical Research conferences, that took place in March and May respectively. Some of these trends and themes include: - More consistent and earlier approach to patient focused drug development (PFDD) - Equitable access to research including health literacy and diversity, equity and inclusion - Measuring impact of patient engagement in research - Improving the sponsor, site and study participant partnership - Participant data release in clinical trials - Compensation for study participants Read the full report to access our key themes and reflections at https://buff.ly/3L7pBnH #PatientsasPartners #ClinicalResearch #PFDD #patientengagement #medcomms #healthliteracy #patients

Understanding the patient perspective and incorporating the patient voice is essential to creating more impactful communications programs and Lumanity's expert patient patient strategy team have collected insights and key themes from the US and European Patients as Partners in Clinical Research conferences that took place earlier this year and published at the link below! If you want to know more about how we can support you in developing concrete patient strategies and programmes, please reach out...!

I've never enjoyed my job more than I do right now - it's such an exciting time in medicines development! In this report, we summarise our key takeaways of where we believe we are now and where we hope to go in patient engagement.

I think there are some very interesting insights in this small survey. I'm very curious to know: how many of you who work in the clinical research and development sector have ever participated in a clinical trial? #clinicaltrials #clinicalresearch

💰🧠 What motivates Americans to participate in clinical trials? Is it financial compensation or understanding the research? Our latest infographic has the answers.

🌍💖 Ever wondered how clinical trials could impact the world? 53% of Americans believe they have the potential to make a positive difference if executed well. Discover more insights in our latest infographic!

🌍💖 Ever wondered how clinical trials could impact the world? 53% of Americans believe they have the potential to make a positive difference if executed well. Discover more insights in our latest infographic!

🌍💖 Ever wondered how clinical trials could impact the world? 53% of Americans believe they have the potential to make a positive difference if executed well. Discover more insights in our latest infographic!

The FDA recently released draft guidance on Diversity Action Plans, a monumental step towards inclusivity in clinical research! The draft guidance outlines the requirements for sponsors to submit Diversity Action Plans, aiming to increase the enrollment of underrepresented groups in clinical trials. This initiative emphasizes the importance of including diverse populations to improve the generalizability and effectiveness of clinical study results. Key Highlights: 🔹 Detailed goals for enrollment disaggregated by race, ethnicity, sex, and age group. 🔹 Rationale for these goals based on disease prevalence and potential differential responses. 🔹 Comprehensive strategies to achieve these enrollment goals, including community engagement and culturally competent practices. At PEP!IN, we are already prepared to help sponsors navigate these new requirements. Our services are designed to ensure compliance while enhancing patient engagement and retention through: - Culturally competent outreach and support. - Patient matching and recruitment services. - Continuous monitoring and reporting to meet FDA guidelines. - Community Outreach Programs. - Patient Education and Awareness Campaigns. - Cultural Competency Training for clinical staff. - Patient Support Services, including logistical support like transportation and flexible scheduling. - Partnerships with Community Organizations to improve outreach and trust. Let’s work together to make clinical trials more inclusive and effective for everyone. Discover how PEP!IN can support your Diversity Action Plan and engagement initiatives by scheduling a consultation today by visiting www.WeArePEPIN.com or emailing us at contact@wearepepin.com. #ClinicalTrials #DiversityInResearch #FDAUpdates #InclusiveScience #PEPIN